Wordt geladen...
5PSQ-003 Effectiveness and safety of vedolizumab in ulcerative colitis and crohn’s disease
BACKGROUND: Vedolizumab is a monoclonal antibody for the treatment of ulcerative colitis and Crohn’s disease. PURPOSE: The aim of this study was to determine the effectiveness and safety of vedolizumab in our hospital since its inclusion in the pharmaceutical guide in April 2016 to the current date...
Bewaard in:
| Gepubliceerd in: | Eur J Hosp Pharm |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Group
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535328/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.357 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|